Researchers use patient data to strengthen clinical prediction models
Cleveland Clinic Cognitive Battery identifies at-risk patients during Medicare annual visits
Pairing machine learning with multi-omics revealed potential therapeutic targets
Recognizing this association aids risk assessment before starting novel immunotherapies
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
GFAP elevation may signal increased risk of progressive regional atrophy, cognitive decline
Study suggests sex-specific pathways show potential for sex-specific therapeutic approaches
For some older adults, a rural setting in late life may be protective
Patients benefit when doctors disclose with care
Criteria-based diagnosis of traumatic encephalopathy syndrome predicts changes in brain volumes and cognition
Plasma proteome analysis aimed at identifying candidate blood-based biomarkers in women
Advertisement
Advertisement